Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.51%
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Aura Biosciences, Inc.
Market Cap
$642.86M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$665.40M
Gross Margin
78.85%
TTM Avg
82.67%
3Y Avg
82.58%
5Y Avg
83.02%
Market Cap
$665.48M
Gross Margin
91.05%
TTM Avg
-190849.07%
3Y Avg
-96132.87%
5Y Avg
-64176.88%
Market Cap
$609.24M
Gross Margin
54.62%
TTM Avg
54.27%
3Y Avg
52.72%
5Y Avg
52.86%
Market Cap
$671.29M
Gross Margin
100.27%
TTM Avg
50.13%
3Y Avg
25.07%
5Y Avg
10.71%
Market Cap
$622.01M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $642.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $640.05M | -18.17% | 40.91% | 70.46% | 80.30% |
| Climb Bio, Inc. (CLYM)vs › | $637.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 78.85% | 82.67% | 82.58% | 83.02% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $665.48M | 91.05% | -190849.07% | -96132.87% | -64176.88% |
| AngioDynamics, Inc. (ANGO)vs › | $609.24M | 54.62% | 54.27% | 52.72% | 52.86% |
| Helus Pharma Inc. (HELP)vs › | $671.29M | 100.27% | 50.13% | 25.07% | 10.71% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $622.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Annexon, Inc. (ANNX)vs › | $682.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fulgent Genetics, Inc. (FLGT)vs › | $601.74M | 35.58% | 39.19% | 43.45% | 55.13% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
